Nakhi, Ali published the artcileTransition metal free hydrolysis/cyclization strategy in a single pot: synthesis of fused furo N-heterocycles of pharmacological interest, SDS of cas: 39267-05-5, the main research area is chloroquinoxaline alkynyl hydrolysis cyclization; furoquinoxaline preparation sirtuins inhibitory activity; furopyrazine preparation sirtuins inhibitory activity.
A transition metal free tandem two-step strategy has been developed involving hydrolysis of 2-chloro-3-alkynyl quinoxalines/pyrazines followed by in situ cyclization of the corresponding 2-hydroxy-3-alkynyl intermediates in a single pot leading to fused furo N-heterocycles as potential inhibitors of sirtuins. A representative compound I showed promising pharmacol. properties in vitro and in vivo.
Organic & Biomolecular Chemistry published new progress about Antitumor agents. 39267-05-5 belongs to class quinoxaline, name is 2,3-Dichloro-6-methylquinoxaline, and the molecular formula is C9H6Cl2N2, SDS of cas: 39267-05-5.
Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider